ATE367445T1 - Viraler paramyxoviridae vektor mit einem defekten hüllprotein-gen - Google Patents

Viraler paramyxoviridae vektor mit einem defekten hüllprotein-gen

Info

Publication number
ATE367445T1
ATE367445T1 AT00927807T AT00927807T ATE367445T1 AT E367445 T1 ATE367445 T1 AT E367445T1 AT 00927807 T AT00927807 T AT 00927807T AT 00927807 T AT00927807 T AT 00927807T AT E367445 T1 ATE367445 T1 AT E367445T1
Authority
AT
Austria
Prior art keywords
gene
deficient
virus
paramyxoviridae
successfully
Prior art date
Application number
AT00927807T
Other languages
English (en)
Inventor
Kaio Kitazato
Tsugumine Shu
Hidekazu Kuma
Yasuji Ueda
Makoto Asakawa
Mamoru Hasegawa
Akihiro Iida
Fumino Tokitou
Takahiro Hirata
Tsuyoshi Tokusumi
Original Assignee
Dnavec Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dnavec Research Inc filed Critical Dnavec Research Inc
Application granted granted Critical
Publication of ATE367445T1 publication Critical patent/ATE367445T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18822—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18841—Use of virus, viral particle or viral elements as a vector
    • C12N2760/18843—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18841—Use of virus, viral particle or viral elements as a vector
    • C12N2760/18845—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18861—Methods of inactivation or attenuation
    • C12N2760/18862—Methods of inactivation or attenuation by genetic engineering
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
    • C12N2810/6072—Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses
    • C12N2810/6081—Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses rhabdoviridae, e.g. VSV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT00927807T 1999-05-18 2000-05-18 Viraler paramyxoviridae vektor mit einem defekten hüllprotein-gen ATE367445T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20073999 1999-05-18

Publications (1)

Publication Number Publication Date
ATE367445T1 true ATE367445T1 (de) 2007-08-15

Family

ID=16429375

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00927807T ATE367445T1 (de) 1999-05-18 2000-05-18 Viraler paramyxoviridae vektor mit einem defekten hüllprotein-gen

Country Status (11)

Country Link
EP (1) EP1186667B1 (de)
JP (2) JP3602058B2 (de)
KR (2) KR20070058607A (de)
CN (1) CN1330767C (de)
AT (1) ATE367445T1 (de)
AU (1) AU4614600A (de)
CA (1) CA2368948C (de)
DE (1) DE60035589T2 (de)
DK (1) DK1186667T3 (de)
ES (1) ES2288473T3 (de)
WO (1) WO2000070070A1 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7241617B2 (en) 1998-07-03 2007-07-10 Dnavec Research, Inc. Sendai viral vectors comprising foreign genes inserted between the R1 and R2 Loci
KR20010074631A (ko) * 1998-07-03 2001-08-04 가부시끼가이샤 디나벡 겡뀨쇼 신경세포용 （－）쇄 ｒｎａ 바이러스 벡터
US7226786B2 (en) 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
WO2001053491A1 (en) * 2000-01-19 2001-07-26 Dnavec Research Inc. Use of paramyxovirus vector in gene transfer into blood vessel
US20020002143A1 (en) 2000-03-30 2002-01-03 Munehide Kano AIDS virus vaccines using sendai virus vector
JP2002142770A (ja) 2000-11-08 2002-05-21 Dnavec Research Inc 循環系への遺伝子送達用パラミクソウイルスベクター
JP4212357B2 (ja) 2000-11-27 2009-01-21 株式会社ディナベック研究所 血管新生遺伝子をコードするパラミクソウイルスベクターおよびその利用
DK1351981T3 (da) 2001-01-19 2012-11-26 Vironovative Bv Et virus, der forårsager luftvejssygdom hos modtagelige pattedyr
US8715922B2 (en) 2001-01-19 2014-05-06 ViroNovative Virus causing respiratory tract illness in susceptible mammals
FR2826010B1 (fr) * 2001-06-14 2005-02-25 Mahmood Salman Al Oligonucleotides antisens capables d'inhiber la formation des tubes capillaires par les cellules endotheliales
EP1437593A1 (de) * 2001-09-18 2004-07-14 Dnavec Research Inc. Verfahren zur untersuchung von (-)-strang-rna-virusvektor mit verrringerter fähigkeit zur partikelbildung sowie verfahren zu seiner konstruktion
JP4553589B2 (ja) 2002-02-21 2010-09-29 メディミューン，エルエルシー 組換えパラインフルエンザウイルス発現系とメタニューモウイルスから得られる異種抗原を含むワクチン
CN1665932B (zh) 2002-04-30 2010-12-15 株式会社载体研究所 具有修饰的蛋白酶依赖向性的载体
KR100587388B1 (ko) * 2003-02-14 2006-06-08 주식회사 효성 고강도 폴리비닐알코올 섬유의 제조방법 및 그로부터수득되는 고강도 폴리비닐알코올 섬유
JP2006524511A (ja) * 2003-04-25 2006-11-02 メッドイミューン バクシーンズ，インコーポレイティド メタニューモウイルス由来の異種抗原を含む組換えパラインフルエンザウイルス発現系およびワクチン
WO2005005645A1 (en) * 2003-06-13 2005-01-20 Apath, Llc Negative strand rna virus replicon
WO2005042737A1 (ja) 2003-11-04 2005-05-12 Dnavec Research Inc. 遺伝子導入された樹状細胞の製造方法
JPWO2005067981A1 (ja) 2004-01-13 2007-12-27 株式会社ディナベック研究所 免疫刺激性サイトカインをコードするマイナス鎖ｒｎａウイルスベクターを用いる腫瘍の遺伝子治療
KR20070004637A (ko) * 2004-01-22 2007-01-09 가부시키가이샤 디나벡크 겐큐쇼 바이러스 벡터의 제조방법
CN1934260B (zh) * 2004-01-22 2013-03-13 株式会社载体研究所 利用含有巨细胞病毒增强子和鸡β-肌动蛋白启动子的杂合启动子制造负链RNA病毒载体的方法
WO2005097988A1 (ja) * 2004-03-23 2005-10-20 Dnavec Research Inc. 組織の維持および／または修復に関連する骨髄関連細胞
US20080031855A1 (en) * 2004-06-24 2008-02-07 Dnavec Research Inc. Anticancer Agent Containing Minus-Strand Rna Virus
JP2008105946A (ja) * 2005-02-08 2008-05-08 Dnavec Corp 遺伝子導入造血細胞から血液細胞を再構築させる方法
DE102005015005A1 (de) * 2005-04-01 2006-10-05 Qiagen Gmbh Verfahren zur Behandlung einer Biomoleküle enthaltenden Probe
EP1916298B1 (de) 2005-06-14 2011-12-28 Dnavec Corporation Verfahren zur herstellung von monoklonalen antikörpern
WO2006137517A1 (ja) * 2005-06-24 2006-12-28 Dnavec Corporation 幼少個体への遺伝子導入用ベクター
CN101351557A (zh) 2005-10-28 2009-01-21 生物载体株式会社 利用以rna病毒或dna病毒的刺突蛋白质假型化的慢病毒载体将基因导入呼吸道上皮干细胞
WO2007061141A1 (ja) * 2005-11-24 2007-05-31 Genomidea, Inc. 改変パラミクソウイルスおよびその作製方法
WO2007083644A1 (ja) 2006-01-17 2007-07-26 Dnavec Corporation 新規タンパク質発現系
KR20090027693A (ko) 2006-05-31 2009-03-17 디나벡크 가부시키가이샤 알츠하이머병 치료제
CA2658266A1 (en) 2006-07-13 2008-01-17 Dnavec Corporation Non-replicating paramyxoviridae virus vector
KR20090114431A (ko) 2007-02-07 2009-11-03 디나벡크 가부시키가이샤 약독화 마이너스 가닥 ｒｎａ 바이러스
JP4936482B2 (ja) * 2007-04-13 2012-05-23 独立行政法人産業技術総合研究所 改良された持続感染型センダイウイルスベクター
US20100203027A1 (en) 2007-04-27 2010-08-12 Kyushu Univeristy National University Viral vector for gene therapy
US9127256B2 (en) 2008-07-16 2015-09-08 Dnavec Corporation Method for production of reprogrammed cell using chromosomally unintegrated virus vector
JPWO2010050586A1 (ja) 2008-10-31 2012-03-29 ディナベック株式会社 組み換え蛋白質の発現を増強する方法
WO2010098419A1 (en) 2009-02-27 2010-09-02 Kyoto University Novel nuclear reprogramming substance
CA2770412C (en) 2009-08-07 2018-09-11 Kyoto University Method of efficiently establishing induced pluripotent stem cells
WO2011037270A1 (en) 2009-09-24 2011-03-31 Kyoto University Method of efficiently establishing induced pluripotent stem cells
KR20120139657A (ko) * 2009-11-02 2012-12-27 고쿠리츠다이가쿠호진 미에다이가쿠 파라믹소바이러스 벡터를 사용한 비강내 분무형 결핵 백신
EP2522360B1 (de) 2010-01-08 2016-11-16 Kyoto University Impfstoff zur tauopathie-behandlung
JP5827220B2 (ja) 2010-01-22 2015-12-02 国立大学法人京都大学 人工多能性幹細胞の樹立効率改善方法
WO2011129446A1 (ja) 2010-04-16 2011-10-20 学校法人慶應義塾 人工多能性幹細胞の製造方法
WO2012029770A1 (ja) 2010-08-30 2012-03-08 ディナベック株式会社 多能性幹細胞を誘導するための組成物およびその使用
JP5794588B2 (ja) 2010-09-14 2015-10-14 国立大学法人京都大学 効率的な人工多能性幹細胞の樹立方法
WO2012053646A1 (ja) 2010-10-22 2012-04-26 国立大学法人北海道大学 ワクシニアウイルスベクターおよびセンダイウイルスベクターからなるプライム／ブーストワクチン用ウイルスベクター
WO2012074106A1 (ja) 2010-12-03 2012-06-07 国立大学法人京都大学 多能性幹細胞からの好酸球の製造方法
EP2647699B1 (de) 2010-12-03 2020-04-01 Kyoto University Effizientes verfahren zur herstellung induzierter pluripotenter stammzellen
WO2012108195A1 (ja) * 2011-02-08 2012-08-16 国立大学法人三重大学 遺伝子導入用ウイルスベクターの製造方法
US9695444B2 (en) 2012-12-26 2017-07-04 BioComo Inc. Vaccine prepared utilizing human parainfluenza virus type 2 vector
US10975358B2 (en) 2013-09-24 2021-04-13 Id Pharma Co., Ltd. Method for improving efficiency of inducing pluripotent stem cell
US20180339038A1 (en) * 2015-06-12 2018-11-29 Mie University Human parainfluenza virus type 2 vector and vaccine
US11103574B2 (en) 2016-11-17 2021-08-31 Japan, as represented by the Director-General of National Institute of Infectious Disease Infectious disease vaccine using non-infectious paramyxovirus particle
WO2019017438A1 (ja) 2017-07-21 2019-01-24 株式会社Ｉｄファーマ 標的配列を改変するためのポリヌクレオチドおよびその使用
EP3744847A4 (de) 2018-01-22 2021-12-08 Japan as Represented by The Director-General of National Institute of Infectious Diseases Selektives cd8-positives t-zellinduzierendes impfstoffantigen
CA3162690A1 (en) 2019-12-31 2021-07-08 Minoru S. H. Ko Temperature-based transient delivery of nucleic acids and proteins to cells and tissues
US20230220025A1 (en) 2020-09-04 2023-07-13 Heartseed Inc. Quality Improving Agent for IPS Cells, Method of Producing IPS Cells, IPS Cells, and Composition for Producing IPS Cells
EP4269571A4 (de) 2020-12-25 2025-01-01 Kyoto University Verfahren zur herstellung von naiven menschlichen ips-zellen aus somatischen zellen
JP2022104813A (ja) 2020-12-29 2022-07-11 アイ ピース，インコーポレイテッド リプログラミング因子を導入された細胞の培養方法
KR20250007525A (ko) 2022-04-25 2025-01-14 도키와-바이오 가부시키가이샤 Rna 바이러스 유래의 키메라 엔벨로프 단백질 및 상기 단백질을 가지는 rna 바이러스 벡터

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512421A (en) * 1991-02-19 1996-04-30 The Regents Of The University Of California Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors
EP0864645B9 (de) * 1995-10-31 2006-03-22 Dnavec Research Inc. Negativstrand rna virus mit selbständiger replikationsaktivität
AU7335296A (en) * 1995-11-01 1997-05-22 Dnavec Research Inc. Recombinant sendai virus
WO1997016171A1 (fr) * 1995-11-01 1997-05-09 Dnavec Research Inc. Liposome a membrane fusible faisant appel a un virus sendai recombinant
ES2307509T3 (es) * 1999-05-18 2008-12-01 Dnavec Research Inc. Complejo ribonucleoproteico en paramixovirus.

Also Published As

Publication number Publication date
JP3602058B2 (ja) 2004-12-15
KR20020014786A (ko) 2002-02-25
KR100739938B1 (ko) 2007-07-16
EP1186667B1 (de) 2007-07-18
AU4614600A (en) 2000-12-05
EP1186667A4 (de) 2004-06-30
JP2004329222A (ja) 2004-11-25
WO2000070070A1 (en) 2000-11-23
CN1330767C (zh) 2007-08-08
CN1355851A (zh) 2002-06-26
CA2368948C (en) 2013-12-24
ES2288473T3 (es) 2008-01-16
DE60035589T2 (de) 2008-04-17
CA2368948A1 (en) 2000-11-23
KR20070058607A (ko) 2007-06-08
DE60035589D1 (de) 2007-08-30
HK1044352A1 (en) 2002-10-18
EP1186667A1 (de) 2002-03-13
DK1186667T3 (da) 2007-10-22

Similar Documents

Publication Publication Date Title
ATE367445T1 (de) Viraler paramyxoviridae vektor mit einem defekten hüllprotein-gen
ES2288866T3 (es) Paramixovirus que contienen una secuencia de inicio de la transcripcion modificada.
DE60033284D1 (de) In vitro-rekonstitution von segmentierten, negativstrang-rna-viren
WO2004113517A3 (en) IMPROVED METHOD FOR THE RECOVERY OF NON-SEGMENTED, NEGATIVE-STRANDED RNA VIRUSES FROM cDNA
JP2018531023A5 (de)
ES2335395T5 (es) Método mejorado para la producción a gran escala de antígenos virales
WO2005062820A3 (en) Multi plasmid system for the production of influenza virus
YU17891A (sh) Dnk koja odgovara genomu virusa sa negativnim lancem rnk, i postupak za dobijanje infektivnih virusa sa negativnim lancem rnk
HRP20200930T1 (hr) Lentivirusni vektori
Nakamura et al. Oncolytic measles viruses for cancer therapy
WO2003068923A3 (en) Signal for packaging of influenza virus vectors
CY1106785T1 (el) Ιικα σωματιδια τα οποια απελευθερωνονται μετα απο μολυνση απο ανθρωπινο κυτταρομεγαλοϊο και η χρηση τους ως εμβολιο
JP2005523318A5 (de)
AU1138388A (en) Hybrid rna virus
IL145702A (en) Method of preparing infectious influenza viruses in the absence of a helper virus
CA2368944A1 (en) Paramyxovirus-derived rnp
WO2001083797A3 (en) Polynucleotides for use in recombinant adeno-associated virus virion production
JP2011507536A5 (de)
WO2005056807A3 (en) Bovine adeno-associated viral (baav) vector and uses thereof
WO2019228117A1 (zh) 慢病毒载体及其递送外源rna的方法
EP1757703A3 (de) Self-inaktivierender Gammaretrovirenvektor
WO2004000220A3 (en) Methods for purifying viral particles for gene therapy
EP1721981A4 (de) Rekombinantes varicella-zoster-virus
DE60231821D1 (de) Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung
JP2025081483A5 (de)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1186667

Country of ref document: EP